Menu
- Microbiology
- Sexual Health
- Pregnancy & Fertility
- Point of Care Tests
- Autoimmune
- Coagulation & Haematology
- Drugs of Abuse
- Clinical Chemistry
- Research Biochemistry
- Food Safety Tests
Following a review of its business relationship with Invitech, BioMedica Diagnostics has decided to grant exclusive distribution rights for Ireland.
Important information received from Orasure regarding intercept i2 and intercept i2he.
Please note our shut down times over the Christmas period.
Orders received after Friday 20th December 2019 will not ship until Thursday 2nd January 2020.
Invitech will close at 12:00 noon on Tuesday 24th December 2019 and will not reopen until Thursday 2nd January 2020.
For urgent matters, please use the Contact Form
To all our customers and suppliers - Happy Christmas and a Prosperous New Year!
We would like to take this opportunity to advise you of the discontinuation of REF ESH-8, Monoclonal Antibody Against Human FVIII. Biomedica has been in possession of the world supply of ESH-8 for many years, regretfully this limited supply has been exhausted.
We are pleased to advise you that we are offering REF ESH-4 as a replacement. ESH-4 is another monoclonal antibody stemming from the original cell line development.
NICE, the National Institute for Health and Care Excellence, has published a new Quality Standard (QS186) that covers diagnosing and managing Lyme Disease in people of all ages. It also includes raising public awareness about prevention.
Invitech and BioMedica Diagnostics are pleased to announce that ACTICLOT® C (REF ACC-45) is now CE marked. Notification has been made to the Belgian Competent Authority that the product fully complies with the In Vitro Diagnostic Directive (IVDD) 98/79 of the European Parliament and of the Council.
ACTICLOT C is intended for the measurement of Protein C activity in human plasma via an endpoint clotting assay.